Melissa McConnell
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,367, more than ten times the $119 reported in 2022. Among family clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$696
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$427
- Lilly USA, LLC$421
- ANI Pharmaceuticals, Inc.$414
- Novo Nordisk$155
- AstraZeneca$151
- plus $994 from 23 others
What the payments were for
- Food & beverage$3,259100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $696 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $427 |
| Lilly USA, LLC | 25 | $421 |
| ANI Pharmaceuticals, Inc. | 30 | $414 |
| Novo Nordisk | 10 | $155 |
| AstraZeneca | 10 | $151 |
| Pfizer | 6 | $109 |
| Dexcom, Inc. | 4 | $89 |
| Axsome Therapeutics, Inc. | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Bayer | 4 | $65 |
| Lundbeck LLC | 3 | $64 |
| GSK | 4 | $63 |
| Antares Pharma, Inc. | 4 | $61 |
| Kowa Pharmaceuticals America, Inc. | 4 | $56 |
| Ferring Pharmaceuticals Inc. | 3 | $55 |
| Boehringer Ingelheim | 3 | $42 |
| Halozyme Inc | 2 | $41 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Verona Pharma, Inc. | 1 | $28 |
| Eisai Inc. | 1 | $27 |
| Johnson & Johnson | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Biogen | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Electromed, Inc. | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 2 | $6 |
How this compares
$3,259 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $482 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 57 | $404 |
| Ketorolac Tromethamine | 21 | $326 |
| Omeprazole | 31 | $254 |
| Cephalexin | 11 | $182 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $147 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 17 | $147 |
| Glipizide ErGlipizide | 13 | $111 |
| Duloxetine Hcl | 17 | $90 |
| Trazodone Hcl | 11 | $90 |
| Prednisone | 35 | $78 |
| Buspirone Hcl | 14 | $55 |
| Finasteride | 11 | $50 |
| Azithromycin | 12 | $48 |
| Sertraline Hcl | 17 | $45 |
Paid to pharmacies, not to this prescriber.
Other family in Troy
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
- Patricia HabdasPittsburgh$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.